Literature DB >> 11469979

Surgical Management of Inflammatory Bowel Disease.

Robert R. Cima1, John H. Pemberton.   

Abstract

Surgery continues to be a central component in the treatment of patients with inflammatory bowel disease (IBD). The most important aspect of caring for patients with IBD is a close and ongoing interaction between the surgeon and gastroenterologist both before and after surgery. Surgery in patients with chronic ulcerative colitis (CUC) is curative. In the appropriate patient, we recommend proctocolectomy with ileal pouch anal anastomosis (IPAA). In contrast, patients with Crohn's disease cannot be cured with surgery. Instead, surgery is used in conjunction with maximal medical therapy to treat symptoms of the disease and improve the patient's quality of life. Surgical interventions should be limited in scope. Small bowel disease should be treated with either limited resection or strictureplasty, if possible, to conserve bowel length. For limited involvement of the colon, segmental resection yields good results. Minimal surgical intervention, drainage of abscesses, placing draining setons, and aggressive medical therapy is recommended as treatment of perianal Crohn's disease.

Entities:  

Year:  2001        PMID: 11469979     DOI: 10.1007/s11938-001-0034-2

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  24 in total

1.  Fulminant Ulcerative Colitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

2.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

Review 3.  Preventing postoperative recurrence of Crohn's disease.

Authors:  N R Borley; N J Mortensen; D P Jewell
Journal:  Br J Surg       Date:  1997-11       Impact factor: 6.939

4.  Perianal Crohn's disease. Results of local surgical treatment.

Authors:  Y P Sangwan; D J Schoetz; J J Murray; P L Roberts; J A Coller
Journal:  Dis Colon Rectum       Date:  1996-05       Impact factor: 4.585

5.  Laparoscopic-assisted vs. open ileocolic resection for Crohn's disease. A comparative study.

Authors:  W A Bemelman; J F Slors; M S Dunker; R A van Hogezand; S J van Deventer; J Ringers; G Griffioen; D J Gouma
Journal:  Surg Endosc       Date:  2000-08       Impact factor: 4.584

6.  Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.

Authors:  C Cammà; M Giunta; M Rosselli; M Cottone
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

7.  Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?

Authors:  S R Gorfine; J J Bauer; M T Harris; I Kreel
Journal:  Dis Colon Rectum       Date:  2000-11       Impact factor: 4.585

8.  Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease.

Authors:  R S McLeod; B G Wolff; A H Steinhart; P W Carryer; K O'Rourke; D F Andrews; J E Blair; J R Cangemi; Z Cohen; J B Cullen; R G Chaytor; G R Greenberg; N M Jaffer; K N Jeejeebhoy; R L MacCarty; R L Ready; L H Weiland
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

Review 9.  Cancer risk in patients with inflammatory bowel disease.

Authors:  J D Lewis; J J Deren; G R Lichtenstein
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

10.  Reoperative rates for Crohn's disease following strictureplasty. Long-term analysis.

Authors:  G Ozuner; V W Fazio; I C Lavery; J W Milsom; S A Strong
Journal:  Dis Colon Rectum       Date:  1996-11       Impact factor: 4.585

View more
  1 in total

Review 1.  Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Authors:  Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Alexa R Weingarden
Journal:  Appl Microbiol Biotechnol       Date:  2016-11-25       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.